Yufen Xiao

机构：Southwestern Medical Center, The University of Texas Southwestern Medical Center · ORCID：0000-0002-5604-7479

发表论文 63 篇 · 总被引 4335 次 · h-index 30

代表论文

• Emerging mRNA technologies: delivery strategies and biomedical applications (2022 · Chemical Society Reviews · 被引 248)
• Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects (2022 · Med · 被引 234)
• In vivo editing of lung stem cells for durable gene correction in mice (2024 · Science · 被引 172)
• Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models (2023 · Nature Communications · 被引 172)
• Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages (2022 · Nature Protocols · 被引 128)
• Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells (2024 · Nature Nanotechnology · 被引 125)